IL1B and inflammatory bowel disease: These consecutive occurrences lead to the activation of the pro-inflammatory cytokines, IL-1β, IL-6, and TNF-α, ultimately resulting in the deterioration of the intestinal epithelial cell barrier and significantly contributing to the pathogenesis of inflammatory bowel disease (Lugo et al., 2007; Sun et al., 2021; Li et al., 2022).